Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS), today announced that it has entered into a collaboration and license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets. Pridopidine is a potent and highly selective, orally administered sigma-1 r...

Ferrer, an international B Corp pharmaceutical company with an increasing focus on rare neurological diseases, and Prilenia Therapeutics B.V., a clinical-stage biotech company, have announced the signing of a strategic co-development and license agreement in which Ferrer obtains the rights to develop, manufacture and commercialize Pridopidine in the European Region, the Middle East and North African Region, the Southern African Region, the Central and South American Region, and the Commonwealth...

AngloGold Ashanti plc (“AngloGold Ashanti”, “AGA” or the “Company”) has agreed to sell its interests in two gold projects in Côte d’Ivoire to Resolute Mining Limited (“Resolute”) as it continues to sharpen its focus on its operating assets and development projects in the United States. The Company will sell Centamin West Africa Holdings Limited (“CWAH”), which owns the Doropo Project and the Archean-Birimian Contact (“ABC”) Project in Côte d’Ivoire (collectively, the “Projects”), to Resolute, ...